Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Roche strengthened by swine flu

July 29, 2009 Sales and Marketing Roche

The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …
News

Genzyme cuts forecasts on production problems

July 29, 2009 Manufacturing and Production, Sales and Marketing Genzyme

The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
News

Merck and Schering-Plough propose shareholder settlement

July 28, 2009 Sales and Marketing MA, Merck

Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
News

GSK to co-market Amgen’s osteoporosis drug in Europe

July 28, 2009 Sales and Marketing Amgen, Deals, GSK

GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
News

Pharma and diagnostics to converge in personalised medicines

July 28, 2009 Research and Development, Sales and Marketing Diagnostics, strategy

News

Sanofi buys Indian vaccines firm

July 27, 2009 Research and Development, Sales and Marketing Asia, Sanofi-Aventis, vaccines

News

Sales strategies for a changing environment

July 24, 2009 Sales and Marketing market access, sales, strategy

Over the last two years the UK pharma industry's established product sales strategies have begun to change. The industry's primary …
Feature

BMS buys Medarex for $2.1 billion

July 24, 2009 Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
News

Generic losses outweigh pandemic pluses for GSK

July 23, 2009 Sales and Marketing GSK

GlaxoSmithKline has reported a 2% fall in sales for the second quarter as growing generic competition in the US bites. …
News

Lupus drug shows surprise phase III success

July 23, 2009 Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
News

Effient ‘unlikely’ to takeover from Plavix

July 23, 2009 Research and Development, Sales and Marketing Effient, cv

News

Kennedy calls for overhaul of NICE processes

July 23, 2009 Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
News

Advertising: be brief, be bold

July 22, 2009 Sales and Marketing Pfizer, advertising, branding

In the pharma industry, do we believe that the gap between what our businesses promise and what results our businesses …
Feature

NICE approves MabThera for leukaemia

July 22, 2009 Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
News

Tracleer expansion fuels Actelion growth

July 22, 2009 Sales and Marketing Actelion, Tracleer

Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026